Showing 123 results
-
Media Release /The Stakeholders Meeting on Leprosy aims to galvanize efforts to achieve zero transmission of leprosy in the Philippines. It was held on July 5-6, 2017 at the Manila Diamond Hotel, with the theme “…
-
Media Release /For many patients with end-stage renal disease (ESRD), the only option for survival is a kidney transplant. Unfortunately in the Philippines, the number of living and deceased kidney donors…
-
Media Release /Secukinumab is the first and only IL-17A inhibitor to show sustained improvements in signs and symptoms of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) Additional data show rapid and…
-
Media Release /Community Partnership Day offers an opportunity for Novartis associates around the world to volunteer and give back to the communities in which they live and work. Novartis Healthcare Philippines…
-
Media Release /New data suggests that disease modification with secukinumab may be achievable for around 20% of patients following one year of treatment1 Patients with longer disease duration before treatment…
-
Media Release /Swiss and Filipino stakeholders in the healthcare sector gather at the Asian Development Bank (ADB) headquarters in Mandaluyong City to present and learn from innovative health policies and…
-
Media Release /Survey shows 85% of respondents are most afraid to lose eye sight of their five senses, 87% of respondents believe regular eye exams are important but only 33% reported visiting annual screenings…
-
Media Release /In line with World Glaucoma Week, Novartis signed a Memorandum of Agreement with the Philippine Glaucoma Society to promote awareness on glaucoma and the importance of regular eye examinations, as…
-
Media Release /Novartis Healthcare Philippines and Philippine Dermatological Society sign Memorandum of Agreement to provide local dermatologists with continuing medical education on psoriasis diagnosis and…
-
Media Release /The European Commission approved ranibizumab to treat patients for visual impairment due to choroidal neovascularization (CNV) associated with causes other than neovascular age-related macular…
